Watchlist Price Alert

Neuronetics Inc. (STIM)

NASDAQ: STIM · Real-Time Price · USD

4.58

0.12 (2.69%)

At close: May 02, 2025, 3:59 PM

4.46

-2.62%

Pre-market: May 05, 2025, 04:01 AM EDT

2.69% (1D)

Bid	4.39
Market Cap	301.43M
Revenue (ttm)	74.89M
Net Income (ttm)	-43.2M
EPS (ttm)	-1.38
PE Ratio (ttm)	-3.32
Forward PE	-19.43
Analyst	Buy

Ask	4.6
Volume	515,491
Avg. Volume (20D)	1,453,859
Open	4.55
Previous Close	4.46
Day's Range	4.44 - 4.64
52-Week Range	0.52 - 5.92
Beta	1.98

About STIM

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, ...

Sector Healthcare

IPO Date Jun 28, 2018

Employees 716

Stock Exchange NASDAQ

Ticker Symbol STIM

Website https://www.neurostar.com

Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for STIM stock is "Buy." The 12-month stock price forecast is $7, which is an increase of 52.84% from the latest price.

Stock Forecasts

Next Earnings Release

Neuronetics Inc. is scheduled to release its earnings on May 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+7.11%

Neuronetics shares are trading higher after Citize... Unlock content with Pro Subscription

2 months ago

-13.76%

Neuronetics shares are trading lower after the company announced the pricing of a $18 million public offering of 8 million shares at $2.25 per share.

News

1 month ago · seekingalpha.com

Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs

Neuronetics has shown significant growth, with a 430% rally since November and strong Q4 2024 results, driven by its NeuroStar TMS therapy system. The company's valuation remains attractive despite re...

1 month ago · zacks.com

Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet

The mean of analysts' price targets for Neuronetics (STIM) points to a 35% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys...

2 months ago · seekingalpha.com

Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript

Neuronetics, Inc. (NASDAQ:STIM ) Q4 2024 Earnings Conference Call March 4, 2025 8:30 AM ET Company Participants Mark Klausner - Investor Relations Keith Sullivan - President & Chief Executive Officer ...